FDA-Approved Psychedelics

Brian Doherty | September 27, 2004

Wired.com reports on some recent moves on the Food and Drug Administration's part to approve clinical trials involving illegal psychedlics and empathogens. Currently, they report, Dr. Charles Grob is using psilocybin to try to treat anxiety in terminal cancer patients; Dr. Francisco Moreno is using the same drug, the most active ingrediant in psychedelic mushrooms, to treat obsessive-compulsive disorder; and the Multidisciplinary Association for Psychedlics Studies is sponsoring MDMA (ecstasy) tests on post-tramautic stress sufferers, all with FDA approval.